Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1

被引:57
作者
Johansen, A
Ek, J
Mortensen, HB
Pedersen, O
Hansen, T
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] Hagedorn Res Inst, DK-2820 Gentofte, Denmark
[3] Glostrup Univ Hosp, DK-2600 Glostrup, Denmark
[4] Univ Copenhagen, Fac Hlth Sci, DK-2200 Copenhagen, Denmark
[5] Aarhus Univ, Fac Hlth Sci, DK-8000 Aarhus, Denmark
关键词
D O I
10.1210/jc.2005-0196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/Hypothesis: Maturity-onset diabetes of the young ( MODY) is a genetically heterogeneous monogenic form of diabetes characterized by an autosomal dominant inheritance, an early clinical onset, and a primary defect in beta-cell function. The aims of the present study were to examine the prevalence and nature of mutations in the three common MODY genes, HNF4A, GCK, and TCF1, in Danish patients with a clinical diagnosis of MODY and to describe metabolic differences in probands with and without mutations in HNF4A, GCK, and TCF1. Methods: Seventy-eight unrelated subjects of Danish Caucasian origin ( 29 men, 49 women) and their 351 family members were examined. The promotor and coding regions including intron-exon boundaries of HNF4A, GCK, and TCF1 were examined by denaturing HPLC and/or direct sequencing. Results: We identified 29 different mutations in 38 MODY families. Fifteen of the mutations were novel. The variants segregated with diabetes within the families, and none of the variants were found in 100 normal Danish chromosomes. Our findings suggest a relative prevalence of 3% of MODY1 (two different mutations in two families), 10% of MODY2 (seven in eight), and 36% of MODY3 ( 21 in 28) among Danish kindred clinically diagnosed as MODY. No significant differences in biochemical and anthropometric measurements were observed at baseline examinations. Conclusions: Forty-nine percent of the families carried mutations in the three examined MODY genes. Our findings highlight that unidentified MODY genes may play a central role for diabetes characterized by autosomal dominant transmission. Furthermore, baseline measurements of various anthropometric and biochemical variables are not appropriate markers of MODYX.
引用
收藏
页码:4607 / 4614
页数:8
相关论文
共 49 条
[21]   Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY [J].
Horikawa, Y ;
Iwasaki, N ;
Hara, M ;
Furuta, H ;
Hinokio, Y ;
Cockburn, BN ;
Lindner, T ;
Yamagata, K ;
Ogata, M ;
Tomonaga, O ;
Kuroki, H ;
Kasahara, T ;
Iwamoto, Y ;
Bell, GI .
NATURE GENETICS, 1997, 17 (04) :384-385
[22]   Mutations in the hepatocyte nuclear factor-1 alpha gene in MODY and early-onset NIDDM - Evidence for a mutational hotspot in exon 4 [J].
Kaisaki, PJ ;
Menzel, S ;
Lindner, T ;
Oda, N ;
Rjasanowski, I ;
Sahm, J ;
Meincke, G ;
Schulze, J ;
Schmechel, H ;
Petzold, C ;
Ledermann, HM ;
Sachse, G ;
Boriraj, VV ;
Menzel, R ;
Kerner, W ;
Turner, RC ;
Yamagata, K ;
Bell, GI .
DIABETES, 1997, 46 (03) :528-535
[23]   MODY in Iceland is associated with mutations in HNF-1α and a novel mutation in NeuroD1 [J].
Kristinsson, SY ;
Thorolfsdottir, ET ;
Talseth, B ;
Steingrimsson, E ;
Thorsson, AV ;
Helgason, T ;
Hreidarsson, AB ;
Arngrimsson, R .
DIABETOLOGIA, 2001, 44 (11) :2098-2103
[24]   High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes [J].
Lehto, M ;
Wipemo, C ;
Ivarsson, SA ;
Lindgren, C ;
Lipsanen-Nyman, M ;
Weng, J ;
Wibell, L ;
Widén, E ;
Tuomi, T ;
Groop, L .
DIABETOLOGIA, 1999, 42 (09) :1131-1137
[25]   Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4 alpha 1/MODY1 gene [J].
Lindner, T ;
Gragnoli, C ;
Furuta, H ;
Cockburn, BN ;
Petzold, C ;
Rietzsch, H ;
Weiss, U ;
Schulze, J ;
Bell, GI .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1400-1405
[26]   A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1β [J].
Lindner, TH ;
Njolstad, PR ;
Horikawa, Y ;
Bostad, L ;
Bell, GI ;
Sovik, O .
HUMAN MOLECULAR GENETICS, 1999, 8 (11) :2001-2008
[27]  
Lindner TH, 1999, DIABETOLOGIA, V42, P121
[28]   Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus [J].
Malecki, MT ;
Jhala, US ;
Antonellis, A ;
Fields, L ;
Doria, A ;
Orban, T ;
Saad, M ;
Warram, JH ;
Montminy, M ;
Krolewski, AS .
NATURE GENETICS, 1999, 23 (03) :323-328
[29]  
Massa O, 2001, DIABETOLOGIA, V44, P898
[30]   Maturity-onset diabetes of the young (MODY) mutation in type 2 diabetes and latent autoimmune diabetes of the adult [J].
McKinney, J ;
Cao, H ;
Behme, MT ;
Mahon, JL ;
Hegele, RA .
DIABETES CARE, 2003, 26 (12) :3358-3359